KFDA to investigate data fabrication of 383 generic drugs

The Korea Food and Drug Administration (KFDA) said it is continuing its additional probe into 383 other generic medicines whose makers are suspected of manipulating test results to report bioequivalence'' to the original, pioneer medicines.

The prosecution also pledged to investigate those involved in the illegal scheme which forced many patients to take low efficacy drugs without knowing th...